Literature DB >> 21409555

Assessing patients for catheter ablation during hospitalization for acute heart failure.

Bradley P Knight1, Jason T Jacobson.   

Abstract

Heart rhythm problems are common among patients who are hospitalized with acute heart failure (HF). Although it is often difficult to determine whether a tachyarrhythmia is the major contributor to an acute HF decompensation or merely a consequence of the decompensation, both issues usually need to be addressed. There is also a subset of patients with HF who have a tachycardia-induced cardiomyopathy (TIC), where the sole cause of the ventricular dysfunction is the heart rhythm problem. In most cases, the management of a tachyarrhythmia in a patient with acute HF is not significantly different than the management of a heart rhythm problem in any patient, but there are several special clinical scenarios and important considerations. These considerations include the time urgency for an intervention, the usual need to be more aggressive and definitive, the need to stabilize a patient to allow for a heart rhythm intervention, such as catheter ablation to be performed safely, and the limitations of antiarrhythmic drugs in patients with ventricular dysfunction. Catheter ablation is a highly effective treatment option for many patients with supraventricular or ventricular tachycardias who are hospitalized with HF. This review will discuss the different types of tachyarrhythmias that can be associated with acute HF and are amenable to catheter ablation, and the assessment that needs to take place in potentially eligible patients to determine when catheter ablation is appropriate.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21409555     DOI: 10.1007/s10741-011-9240-8

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  38 in total

1.  Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias.

Authors:  Michel Haïssaguerre; Mélèze Hocini; Prashanthan Sanders; Frederic Sacher; Martin Rotter; Yoshihide Takahashi; Thomas Rostock; Li-Fern Hsu; Pierre Bordachar; Sylvain Reuter; Raymond Roudaut; Jacques Clémenty; Pierre Jaïs
Journal:  J Cardiovasc Electrophysiol       Date:  2005-11

2.  Suppression of frequent premature ventricular contractions and improvement of left ventricular function in patients with presumed idiopathic dilated cardiomyopathy.

Authors:  D F Duffee; W K Shen; H C Smith
Journal:  Mayo Clin Proc       Date:  1998-05       Impact factor: 7.616

3.  A new technique to perform epicardial mapping in the electrophysiology laboratory.

Authors:  E Sosa; M Scanavacca; A d'Avila; F Pilleggi
Journal:  J Cardiovasc Electrophysiol       Date:  1996-06

Review 4.  Management of atrial fibrillation in the setting of heart failure.

Authors:  H J Crijns; M P Van den Berg; I C Van Gelder; D J Van Veldhuisen
Journal:  Eur Heart J       Date:  1997-05       Impact factor: 29.983

5.  Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy.

Authors:  F E Marchlinski; D J Callans; C D Gottlieb; E Zado
Journal:  Circulation       Date:  2000-03-21       Impact factor: 29.690

6.  Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation.

Authors:  Hakan Oral; Bradley P Knight; Hiroshi Tada; Mehmet Ozaydin; Aman Chugh; Sohail Hassan; Christoph Scharf; Steve W K Lai; Radmira Greenstein; Frank Pelosi; S Adam Strickberger; Fred Morady
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

7.  Use of adenosine in patients hospitalized in a university medical center.

Authors:  B P Knight; A Zivin; J Souza; R Goyal; K C Man; A Strickberger; F Morady
Journal:  Am J Med       Date:  1998-10       Impact factor: 4.965

8.  Mode of initiation and ablation of ventricular fibrillation storms in patients with ischemic cardiomyopathy.

Authors:  Nassir F Marrouche; Atul Verma; Oussama Wazni; Robert Schweikert; David O Martin; Walid Saliba; Fethi Kilicaslan; Jennifer Cummings; J David Burkhardt; Mandeep Bhargava; Dianna Bash; Johannes Brachmann; Jens Guenther; Steven Hao; Salwa Beheiry; Antonio Rossillo; Antonio Raviele; Sakis Themistoclakis; Andrea Natale
Journal:  J Am Coll Cardiol       Date:  2004-05-05       Impact factor: 24.094

9.  Adverse effects of Wolff-Parkinson-White syndrome with right septal or posteroseptal accessory pathways on cardiac function.

Authors:  Maren Tomaske; Jan Janousek; Vít Rázek; Roman A Gebauer; Viktor Tomek; Gerd Hindricks; Walter Knirsch; Urs Bauersfeld
Journal:  Europace       Date:  2008-02       Impact factor: 5.214

10.  Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.

Authors:  Karl-Heinz Kuck; Anselm Schaumann; Lars Eckardt; Stephan Willems; Rodolfo Ventura; Etienne Delacrétaz; Heinz-Friedrich Pitschner; Josef Kautzner; Burghard Schumacher; Peter S Hansen
Journal:  Lancet       Date:  2010-01-02       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.